XML 160 R147.htm IDEA: XBRL DOCUMENT v3.6.0.2
Schedule II Condensed Financial Information of Registrant - Condensed Cash Flow
€ in Millions, $ in Millions
9 Months Ended 12 Months Ended
Sep. 30, 2015
EUR (€)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities   $ 1,199 $ 1,049 $ 599
Cash flows from investing activities        
Investment in note receivable | € € (5)      
Purchases of:        
Net cash (used in) provided by investing activities   (2,602) (52) 1,332
Cash flows from financing activities        
Net cash provided by (used in) financing activities   1,155 (911) (2,328)
Net (decrease) increase in cash and cash equivalents   (261) 82 (397)
Cash and cash equivalents at beginning of year [1]   2,720 2,638 3,035
Cash and cash equivalents at end of year [1]   2,459 2,720 2,638
Supplementary information        
Cash paid for interest   9 22 56
Non-cash transactions        
Issuance of capital for payment of liabilities   0 0 199
Parent Company        
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities   (45) (82) 319
Cash flows from investing activities        
Capital contributions to subsidiary   (34) (506) (232)
Acquisition of subsidiaries, net of cash acquired   0 0 33
Receipts on loans to subsidiaries   20 188 0
Issuances of loans to subsidiaries   0 (103) (100)
Investment in note receivable   0 (5) 0
Sales, maturities, and repayments of:        
Available-for-sale, fixed maturity securities   5 17 9
Purchases of:        
Available-for-sale, fixed maturity securities (related party: 2016 – $0, 2015 – $0, and 2014 – $(38))   (3) (423) (294)
Cash settlement of derivatives   5 0 0
Other investing activities, net   (5) 0 0
Net cash (used in) provided by investing activities   (12) (832) (584)
Cash flows from financing activities        
Capital contributions   1 1,116 305
Repayment of note payables   0 0 (300)
Net change in cash collateral posted for derivative transactions   6 0 0
Repurchase of common stock   (21) (3) (78)
Net cash provided by (used in) financing activities   (14) 1,113 (73)
Net (decrease) increase in cash and cash equivalents   (71) 199 (338)
Cash and cash equivalents at beginning of year   260 61 399
Cash and cash equivalents at end of year   189 260 61
Supplementary information        
Cash paid for interest   0 0 1
Non-cash transactions        
Non-cash capital contribution to ALRe   0 708 0
Issuance of capital for payment of liabilities   $ 0 $ 2 $ 199
[1] Includes cash and cash equivalents of consolidated variable interest entities